Breast cancer claims younger black female lives. If so, when should the screening begin?

Published Date: 26 Apr 2023

Once a woman turns 40, experts advise that she at the very least think about starting a breast cancer screening program. According to a recent study, Black women need this advice above all others.

Read Full News

Latest News

Apr 24 2026 This Week in Cardiology

PCSK9 inhibitors in high-risk diabetes without ASCVD, the CAAN-AF trial, conduction system pacing vs biventricular pacing, PFA and stroke, and therapeutic fashion infects expert consensus are the topics John Mandrola, MD, discusses in this week's podcast.

Drug Therapy in Nonobstructive Hypertrophic Cardiomyopathy

A commentary on the first randomized trial of beta blockers vs calcium channel blockers in nonobstructive HCM that support a necessary re-evaluation of beta blockers across the spectrum of HCM.

Look Once, Think Twice: The Art of Neurologic Diagnosis

Many neurologic conditions hide behind subtle signs, and neurophobia can further confound the diagnosis. A neurologists provides tips on when to pause and think again.

Beta-Blocker Use After Myocardial Infarction: When to Stop?

New trial data question routine long term beta blocker use after myocardial infarction in stable patients with preserved function, prompting reassessment of continuation decisions.

Ready or Not, LLMs Are Coming for Medicine

Current chatbots might show deficiencies in clinical reasoning for now, but don’t hold your breath.

SGO 2026

Read clinically focused news coverage of key developments from SGO 2026

Todays Updates

Which Risk Model Better Identifies High-Risk Smoldering MM?

A cohort study compares the distribution and progression risk among individuals classified as having high-risk smoldering multiple myeloma by the AQUILA trial inclusion criteria vs 2/20/20 risk model.

Todays Updates

Which Risk Model Better Identifies High-Risk Smoldering MM?

A cohort study compares the distribution and progression risk among individuals classified as having high-risk smoldering multiple myeloma by the AQUILA trial inclusion criteria vs 2/20/20 risk model.

Latest News

PCSK9 inhibitors in high-risk diabetes without ASCVD, the CAAN-AF trial, conduction system pacing vs biventricular pacing, PFA and stroke, and therapeutic fashion infects expert consensus are the topics John Mandrola, MD, discusses in this week's podcast.

A commentary on the first randomized trial of beta blockers vs calcium channel blockers in nonobstructive HCM that support a necessary re-evaluation of beta blockers across the spectrum of HCM.

Many neurologic conditions hide behind subtle signs, and neurophobia can further confound the diagnosis. A neurologists provides tips on when to pause and think again.

New trial data question routine long term beta blocker use after myocardial infarction in stable patients with preserved function, prompting reassessment of continuation decisions.

Current chatbots might show deficiencies in clinical reasoning for now, but don’t hold your breath.

Read clinically focused news coverage of key developments from SGO 2026

News All Time

Incidentalomas and Anxiety in Whole-Body Screening

Dr Bishal Gyawali discusses the rising trend of whole-body scans for cancer screening and how they can cause more harm than good.

Enhancing Shared Decision-Making in Early Breast Cancer

Experts discuss communication approaches that enhance shared decision-making for patients with early breast cancer, spanning surgery, adjuvant therapy, and survivorship.

Bannwarth Syndrome in a Woman With Early Breast Cancer

The case emphasizes Bannwarth syndrome as a rare but treatable cause of neurologic deterioration in an older woman receiving surgical cancer care.

Can Large Language Models Simplify Radiology Reports?

A meta-analysis suggests that large language model-simplified radiology reports improve patient understanding and readability while preserving high accuracy and completeness.

NPH: What You Learned in Med School Is Wrong

Neurologists Indu Subramanian and Alfonso Fasano discuss normal pressure hydrocephalus and why some of the classic dogma about this condition is wrong.

Promoting Whole-Body Imaging: Not There Yet

Ethicist Art Caplan discusses marketing promotions for expensive whole-body imaging.

Medicine Will Turn Cellular Age Backward by 2050: Barzilai

Aging may not be permanent. Nir Barzilai explains how human cells reset to zero and why partial rejuvenation could be possible within decades.

Adding to the Toolbox: Thyroid Artery Embolization

Drs Kaniksha Desai and Juan Camacho discuss thyroid artery embolization.

The Time Burden of Cancer Treatment

Dr Kathy Miller discusses a recent study quantifying the hidden time burden of cancer care and its impact on clinic operations and patient experience.

ASCO GI: Updates in Pancreatic, Gastric, CRC

Dr Emil Lou highlights practice-changing updates from ASCO GI, including new immunotherapy, targeted therapy, and circulating tumor DNA advances across gastrointestinal cancers.

High-speed imaging tracks live brain cell activity in awake mice

A research team from the School of Engineering at The Hong Kong University of Science and Technology (HKUST) has achieved a breakthrough in brain imaging by developing the world's first technology to capture high-resolution ...

Study highlights AI limits in heart care

There are limits in applying AI to images of the heart, according to a new study from the Smidt Heart Institute at Cedars-Sinai published in the Journal of the American Society of Echocardiography.

New material may outperform current agents used in medical imaging

Scientists at Oregon State University have filed a patent on a design for a new magnetic resonance imaging contrast agent with the potential to outperform current agents while being less toxic to patients and more environmentally ...

New brain atlas offers unprecedented detail in MRI scans

A new AI-assisted brain atlas that can help visualize the human brain in unprecedented detail has been developed by UCL researchers, in a major step forward for neuroscience and neuroimaging.

Imaging technique maps the brain's nerve fiber labyrinth with micrometer precision

In order to understand brain diseases, neuroscientists try to untangle the intricate nerve fiber labyrinth of our brain. Before analyzing brain tissue under a microscope, it is often soaked in paraffin wax to achieve high-quality ...

Holographic optogenetics could enable faster brain mapping for new discoveries

Recent technological advances have opened new possibilities for neuroscience research, allowing researchers to map the brain's structure and synaptic connectivity (i.e., the junctions via which neurons communicate with each ...

Recommended News For You

First-Line HCC Trial's Lenvatinib-Pembrolizumab Combo Misses Target.

Upping Immunotherapy Activity; A Win for Lung Screening; Looming Drug Price Break?

Error on the MGUS-Autoimmune Disease Association.

Belzutifan Combo Could be Second-Line Option in Advanced RCC

What Comes After Cancer?

Navigating breast cancer diagnosis, treatment, and survivorship in Ethiopia

EGFR Inhibitors for Lung Cancer Tied to Increased Keratitis Risk.

Recommended Articles For You

What You Need to Know about Hairy Cell Leukemia: A Comprehensive Guide  

Unlocking the Secret to Accurate ANC Calculation with This Informative Blog Post 

Abemaciclib in Combination with Therapies for Patients with Metastatic Breast Cancer 

A Closer Look at Poorly Differentiated Carcinoma: Uncovering its Complexities 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Top 10 questions about breast cancer answered

2.

Insurance Claim Denials for Preventive Care More Common in At-Risk Patients

3.

ACS Guidelines Expand Lung Cancer Screening Eligibility -- Is That a Good Thing?

4.

Immunotherapy after surgery is good for patients with advanced cancer

5.

Alecensa (alectinib) Offers Hope for Certain Patients With ALK Positive NSCLC

1.

Cerebrospinal Fluid Metabolite Biomarkers in Central Nervous System Tumor Monitoring: A New Frontier

2.

Introduction To Immune Thrombocytopenic Purpura

3.

Demystifying the Mentzer Index: Understanding Its Importance in Inventory Management 

4.

The Ins and Outs of Glossectomy: What You Need to Know 

5.

What is Hemorrhagic Cystitis and How to Manage its Symptoms

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II

2.

Efficient Management of First line ALK-rearranged NSCLC - Part V

3.

The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion

4.

L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients

5.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot